Comparison of early patient-reported outcomes between uniportal thoracoscopic segmentectomy and wedge resection for peripheral small-sized non-small-cell lung cancer

Background Analysis of patient-reported outcomes (PROs) offers valuable insights into distinguishing the effects of closely related medical procedures from the patient’s perspective. In this study we compared symptom burden in patients undergoing uniportal thoracoscopic segmentectomy and wedge resection for peripheral small-sized non-small cell lung cancer (NSCLC). Methods This study included patients with peripheral NSCLC from an ongoing longitudinal prospective cohort study (CN-PRO-Lung 3) who underwent segmentectomy or wedge resection with tumor diameter ≤ 2 cm and consolidation tumor ratio (CTR) ≤ 0.5. PROs data were collected using the Perioperative Symptom Assessment for Lung Surgery questionnaire pre-operatively, daily post-surgery up to the fourth hospitalization day, and weekly post-discharge up to the fourth week. Propensity score matching and a generalized estimation equation model were employed to compare symptom severity. In addition, short-term clinical outcomes were compared. Results In total, data of 286 patients (82.4%) undergoing segmentectomy and 61 patients (17.6%) undergoing wedge resection were extracted from the cohort. No statistically significant differences were found in the proportion of moderate-to-severe symptoms and mean scores for pain, cough, shortness of breath, disturbed sleep, fatigue, drowsiness, and distress during the 4-day postoperative hospitalization or the 4-week post-discharge period before or after matching (all p > 0.05). Compared with segmentectomy, wedge resection showed better short-term clinical outcomes, including shorter operative time (p = 0.001), less intraoperative bleeding (p = 0.046), and lower total hospital costs (p = 0.002). Conclusions The study findings indicate that uniportal thoracoscopic segmentectomy and wedge resection exert similar early postoperative symptom burden in patients with peripheral NSCLC (tumor diameter ≤ 2 cm and CTR ≤ 0.5). Clinical trial registration Not applicable..

Medienart:	E-Artikel

Erscheinungsjahr:	2024
Erschienen:	2024

Enthalten in:	Zur Gesamtaufnahme - volume:19
Enthalten in:	Journal of cardiothoracic surgery - 19(2024), 1 vom: 15. Apr.

Sprache:	Englisch

Beteiligte Personen:	Zhao, Yingzhi [VerfasserIn] Liu, Wenwu [VerfasserIn] Gao, Xin [VerfasserIn] Zhang, Kaixin [VerfasserIn] Dai, Wei [VerfasserIn] Wei, Xing [VerfasserIn] Zheng, Haoqian [VerfasserIn] Lei, Cheng [VerfasserIn] Yu, Hongfan [VerfasserIn] Shi, Qiuling [VerfasserIn] Li, Qiang [VerfasserIn] Xie, Tianpeng [VerfasserIn]

Links:	Volltext [kostenfrei]

Themen:	Non-small cell lung carcinoma Patient-reported outcomes Pneumonectomy

Anmerkungen:	© The Author(s) 2024

doi:	10.1186/s13019-024-02635-9

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	SPR055531792